31 Oct 2025

"Pandion Energy Completes Sale of Key Norwegian Assets to INPEX Idemitsu Norge AS"

"Pandion Energy has successfully completed the sale of its interests in the Valhall, Hod, Slagugle, and Mistral fields to INPEX Idemitsu Norge AS, marking a significant step in its portfolio management strategy. The transaction, advised by Arntzen Grette, covers seven production licenses and allows Pandion Energy to unlock substantial value while focusing on future investments and development of other assets like the Nova field and discoveries such as Ofelia and Sierra Solberg."

Arntzen Grette advised Pandion Energy in the transaction involving the sale of its participating interests in the Valhall and Hod fields, as well as the Slagugle and Mistral discoveries, to INPEX Idemitsu Norge AS. The transaction, announced on 22 July 2025, involved Pandion Energy selling its participating interests in three key assets on the Norwegian Continental Shelf: Valhall and Hod (10%), Slagugle (20%), and Mistral (20%). The deal covered a total of seven production licences and was completed following receipt of necessary approvals, including from the Ministry of Energy. This transaction represents a significant step in Pandion Energy’s portfolio management strategy, enabling the company to realise substantial value and strengthen its ability to invest in future portfolio development. Arntzen Grette’s core team advising Pandion Energy consisted of Per Dagslet, Karl Erik Navestad, and Asgeir Lehmann. Their seniority and practice areas were not specified in the press release.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.